Natacha Pisarenko / APA laboratory technician works at the mAbxience biopharmaceutical company in Garin, Argentina, on Aug. 14, 2020. Under an agreement between Argentina and Mexico announced last month, the company is going to make an experimental coronavirus vaccine developed by Oxford University and the laboratory AstraZeneca, and if approved, the vaccine will be distributed in Latin America. (Natacha Pisarenko / AP)
By Jack Davis
Published September 13, 2020 at 7:25am
Pharmaceutical giant AstraZeneca announced Saturday that its phase three coronavirus vaccine trial is back in business.
“Clinical trials for the AstraZeneca Oxford coronavirus vaccine, AZD1222, have resumed in the UK following confirmation by the Medicines Health Regulatory Authority (MHRA) that it was safe to do so,” the company said in a media release.
“On 6 September, the standard review process triggered a voluntary pause to vaccination across all global trials to allow review of safety data